BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29054399)

  • 1. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
    Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
    J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM Study.
    Mareschal S; Ruminy P; Bagacean C; Marchand V; Cornic M; Jais JP; Figeac M; Picquenot JM; Molina TJ; Fest T; Salles G; Haioun C; Leroy K; Tilly H; Jardin F
    J Mol Diagn; 2015 Apr; ():. PubMed ID: 25891505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of reverse transcriptase - Multiplex ligation-dependant probe amplification (RT-MLPA) in the molecular classification of Diffuse Large B cell lymphoma (DLBCL) by cell-of-origin (COO).
    Dcunha N; Sakhti D; Sigamani E; Chandramohan J; Korula A; George B; Manipadam MT; Pai R
    Indian J Pathol Microbiol; 2023; 66(4):714-719. PubMed ID: 38084521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma.
    Linton K; Howarth C; Wappett M; Newton G; Lachel C; Iqbal J; Pepper S; Byers R; Chan WJ; Radford J
    J Mol Diagn; 2012; 14(3):223-32. PubMed ID: 22446084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma.
    Hall JS; Usher S; Byers RJ; Higgins RC; Memon D; Radford JA; Linton KM
    J Mol Diagn; 2015 Jul; 17(4):402-11. PubMed ID: 25982535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues.
    Rimsza LM; Wright G; Schwartz M; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Cook JR; Tubbs RR; Braziel RM; Delabie J; Miller TP; Staudt LM
    Clin Cancer Res; 2011 Jun; 17(11):3727-32. PubMed ID: 21364035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.
    Choi JW; Kim Y; Lee JH; Kim YS
    Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCR.
    Xue X; Zeng N; Gao Z; Du MQ
    Lab Invest; 2015 Jan; 95(1):113-20. PubMed ID: 25418578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues.
    Chen J; Byrne GE; Lossos IS
    Diagn Mol Pathol; 2007 Jun; 16(2):61-72. PubMed ID: 17525674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.
    Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation.
    Xue X; Huang W; Qiu T; Guo L; Ying J; Lv N
    BMC Cancer; 2020 Aug; 20(1):816. PubMed ID: 32854650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.
    Collie AM; Nölling J; Divakar KM; Lin JJ; Carver P; Durkin LM; Hill BT; Smith MR; Radivoyevitch T; Kong LI; Daly T; Murugesan G; Guenther-Johnson J; Dave SS; Manilich EA; Hsi ED
    Br J Haematol; 2014 Oct; 167(2):281-5. PubMed ID: 24961756
    [No Abstract]   [Full Text] [Related]  

  • 15. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
    Michaelsen TY; Richter J; Brøndum RF; Klapper W; Johnsen HE; Albertsen M; Dybkær K; Bøgsted M
    Blood Adv; 2018 Jul; 2(13):1542-1546. PubMed ID: 29967255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
    Maesako Y; Uchiyama T; Ohno H
    Cancer Sci; 2003 Sep; 94(9):774-81. PubMed ID: 12967475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray-based classification of diffuse large B-cell lymphoma.
    Poulsen CB; Borup R; Nielsen FC; Borregaard N; Hansen M; Grønbaek K; Møller MB; Ralfkiaer E
    Eur J Haematol; 2005 Jun; 74(6):453-65. PubMed ID: 15876249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
    Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
    Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYD88 Mutations and Sensitivity to Ibrutinib Therapy.
    Wang YL
    J Mol Diagn; 2018 Mar; 20(2):264-266. PubMed ID: 29482770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma.
    Iqbal J; Joshi S; Patel KN; Javed SI; Kucuk C; Aabida A; d'Amore F; Fu K
    Indian J Cancer; 2007; 44(2):72-86. PubMed ID: 17938484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.